{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:57:01Z","timestamp":1785621421361,"version":"3.56.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>There is a striking variation in national doxycycline post exposure prophylaxis (doxyPEP) guidelines for sexually transmitted infections (STIs). Whilst some countries advocate doxyPEP for all men who have sex with men (MSM) and transgender women (TGW) with certain risks, others restrict the use to research settings. In this viewpoint, we argue that part of the explanation for this divergence can be attributed to different underlying conceptual frameworks. For individuals and organizations dominated by biomedical individualist frameworks, the primary goal of STI services is reducing the incidence of STIs. We have good evidence that doxyPEP does this and therefore, particularly in the setting of increasing STI incidence, this framework regards it as logical to roll out doxyPEP as fast as possible. By way of contrast, if organizations and their members operate within an ecosocial framework then their primary goal is the optimization of the sexual and overall health of individuals and populations and not just reducing STI rates. This framework sees the prevalence of STIs as being driven by the connectivity of local sexual networks. Recent increases in STI prevalence are seen as being due to increased network connectivity. The intensive use of antimicrobials such as doxycycline to reduce this prevalence is seen as introducing a selection pressure for the emergence of resistance to tetracyclines and other antimicrobials in <jats:italic>N. gonorrhoeae<\/jats:italic> and other species. This plus the other risks of doxyPEP, leads those animated by this framework to tend toward the precautionary principle and restrict the use of doxyPEP to research settings. The differences in these two frameworks thus leads different individuals and organizations with access to the same evidence-base to very different conclusions as to the net risk-benefit of doxyPEP.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1616111","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T01:23:17Z","timestamp":1750382597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Where we stand on doxyPEP depends on where we sit: a viewpoint"],"prefix":"10.3389","volume":"16","author":[{"given":"Thibaut","family":"Vanbaelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumo","family":"Kanesaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba Santhini","family":"Manoharan-Basil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/1040841X.2023.2274849","article-title":"The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea.","volume":"50","author":"Adamczyk-Pop\u0142awska","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00007435-199905000-00004","article-title":"Sexual network patterns as determinants of STD rates: Paradigm shift in the behavioral epidemiology of STDs made visible.","volume":"26","author":"Aral","year":"1999","journal-title":"Sex Transm. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1258\/0956462011922814","article-title":"Sexually transmitted diseases: Magnitude, determinants and consequences.","volume":"12","author":"Aral","year":"2001","journal-title":"Int. J. STD AIDS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention.","volume":"73","author":"Bachmann","year":"2024","journal-title":"United States, 2024. MMWR. Recommendations Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance.","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B6","author":"Bercot","year":"","journal-title":"Antimicrobial Resistance in Neisseria Gonorrhoeae Infections Among MSM using Doxycycline Post-Exposure Prophylaxis. A Substudy of the ANRS DOXYVAC Trial. 37th IUSTI."},{"key":"B7","doi-asserted-by":"publisher","first-page":"BJGO.2020.0181","DOI":"10.3399\/BJGPO.2020.0181","article-title":"Is there an association between long-term antibiotics for acne and subsequent infection sequelae and antimicrobial resistance? A systematic review.","volume":"5","author":"Bhate","year":"2021","journal-title":"BJGP Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/QAI.0b013e31815e4062","article-title":"Decreases in AIDS mortality and increases in primary and secondary syphilis in men who have sex with men in the United States.","volume":"47","author":"Chesson","year":"2008","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00007435-200305000-00008","article-title":"AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s.","volume":"30","author":"Chesson","year":"2003","journal-title":"Sex Transm. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/09564624241308026","article-title":"DOXY do, or DOXY Don\u2019t? Syphilis and doxycycline post-exposure prophylaxis: A case report.","volume":"36","author":"Chircop","year":"2025","journal-title":"Int. J. STD AIDS"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2352-3018(19)30186-9","article-title":"Use of doxycycline prophylaxis among gay and bisexual men in Melbourne.","volume":"6","author":"Chow","year":"2019","journal-title":"Lancet HIV"},{"key":"B12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-024-03274-2","article-title":"Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.","volume":"31","author":"Chu","year":"2025","journal-title":"Nat. Med."},{"key":"B13","article-title":"Impact of doxycycline as STI PEP on the gut microbiome and antimicrobial resistance gene expression","author":"Chu","year":"2024","journal-title":"Proceedings of the Conference on Retroviruses and Opportunistic Infections"},{"key":"B14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5694\/mja2.52258","article-title":"Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.","volume":"220","author":"Cornelisse","year":"2024","journal-title":"Med. J. Australia"},{"key":"B15","author":"De Scheerder","year":"2024","journal-title":"Doxy Post-Exposure Prophylaxis for STI Not Endorsed by BREACH. Belgium Research on AIDS and HIV Consortium."},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40794-018-0074-4","article-title":"A review of antibiotic prophylaxis for traveler\u2019s diarrhea: Past to present.","volume":"4","author":"Diptyanusa","year":"2018","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/sextrans-2019-054325","article-title":"Use of doxycycline and other antibiotics to prevent STIs among men who have sex with men visiting sexual health clinics in the Netherlands.","volume":"96","author":"Evers","year":"2020","journal-title":"Sex Transm. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1177\/09564624231190108","article-title":"Doxycycline post exposure prophylaxis could select for cross-resistance to other antimicrobials in various pathogens: An in silico analysis.","volume":"34","author":"Gestels","year":"2023","journal-title":"Int. J. STD AIDS"},{"key":"B19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: A cross-national database study.","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1056\/NEJM197905103001903","article-title":"A trial of minocycline given after exposure to prevent gonorrhea.","volume":"300","author":"Harrison","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-02200-6_3","article-title":"An overview of social and behavioral determinants of STI","author":"Hogben","year":"2020","journal-title":"Sexually Transmitted Infections"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s15010-023-02086-9","article-title":"Already current practice? A snapshot survey on doxycycline use for prevention of sexually transmitted infections in parts of the German MSM community.","volume":"51","author":"Hornuss","year":"2023","journal-title":"Infection"},{"key":"B23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/cid\/ciy048","article-title":"Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.","volume":"67","author":"Kenyon","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/OLQ.0000000000001199","article-title":"Does intense STI screening cause or prevent antimicrobial resistance in STIs? It depends on one\u2019s underlying epistemology. A viewpoint.","volume":"47","author":"Kenyon","year":"2020","journal-title":"Sex Transm. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106974","DOI":"10.1016\/j.ijid.2024.02.017","article-title":"Doxycycline post-exposure prophylaxis could theoretically select for resistance to various antimicrobials in 19 pathobionts: An in silico analysis.","volume":"142","author":"Kenyon","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.12688\/f1000research.17148.2","article-title":"It\u2019s the network, stupid: A population\u2019s sexual network connectivity determines its STI prevalence.","volume":"7","author":"Kenyon","year":"2018","journal-title":"F1000Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3201\/eid2407.172104","article-title":"Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae.","volume":"24","author":"Kenyon","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/0956462420957519","article-title":"Screening for STIs in PrEP cohorts results in high levels of antimicrobial consumption.","volume":"31","author":"Kenyon","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/OLQ.0000000000001404","article-title":"The population-level effect of screening for M. genitalium on antimicrobial resistance: A quasi-experimental study.","volume":"48","author":"Kenyon","year":"2021","journal-title":"Sex Transm. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.lanepe.2023.100743","article-title":"Management of asymptomatic sexually transmitted infections in Europe: Towards a differentiated, evidence-based approach.","volume":"34","author":"Kenyon","year":"2023","journal-title":"Lancet Regional Health Eur."},{"key":"B31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/09564624211064133","article-title":"Recent insights suggest the need for the STI field to embrace a more eco-social conceptual framework: A viewpoint.","volume":"33","author":"Kenyon","year":"2022","journal-title":"Int. J. STD AIDS"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/jac\/dkad129","article-title":"Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections.","volume":"78","author":"Kong","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0277-9536(94)90202-x","article-title":"Epidemiology and the web of causation: Has anyone seen the spider?","volume":"39","author":"Krieger","year":"1994","journal-title":"Soc. Sci. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/antibiotics11020268","article-title":"Screening of anorectal and oropharyngeal samples fails to detect bacteriophages infecting Neisseria gonorrhoeae.","volume":"11","author":"Laumen","year":"2022","journal-title":"Antibiotics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1473-3099(16)30397-8","article-title":"Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: A non-linear time-series analysis.","volume":"17","author":"Lawes","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"iv47","DOI":"10.1136\/sextrans-2013-051020","article-title":"The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.","volume":"89","author":"Lewis","year":"2013","journal-title":"Sex Transm. Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3201\/eid0804.010312","article-title":"Antimicrobial use and antimicrobial resistance: A population perspective.","volume":"8","author":"Lipsitch","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00085-4","article-title":"Doxycycline to prevent bacterial sexually transmitted infections in the USA: Final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.","author":"Luetkemeyer","year":"2025","journal-title":"Lancet Infect. Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections.","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"New Engl. J. Med."},{"key":"B40","first-page":"226","volume":"25","author":"Luetkemeyer","year":"2022","journal-title":"Doxycycline Post-Exposure Prophylaxis for STI Prevention Among MSM and Transgender Women on HIV PrEP or Living with HIV: High Efficacy to Reduce Incident STI\u2019s in a Randomized Trial., in JAIDS."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2300621","DOI":"10.2807\/1560-7917.ES.2023.28.46.2300621","article-title":"Using doxycycline for prophylaxis of bacterial sexually transmitted infections: Considerations for the European Union and European Economic Area.","volume":"28","author":"M\u00e5rdh","year":"2023","journal-title":"Euro Surveill."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.lanepe.2023.100742","article-title":"Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe.","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Regional Health Eur."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): A multicentre, open-label, randomised trial with a 2\u00d7 2 factorial design.","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect. Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: An open-label randomised substudy of the ANRS IPERGAY trial.","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/mdr.2004.10.231","article-title":"Tetracycline and macrolide co-resistance in Streptococcus pyogenes: Co-selection as a reason for increase in macrolide-resistant S. pyogenes?","volume":"10","author":"Nielsen","year":"2004","journal-title":"Microb. Drug Resist."},{"key":"B46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/sextrans-2024-056240","article-title":"Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis.","volume":"100","author":"Raccagni","year":"2024","journal-title":"Sex Transm. Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/S2666-5247(24)00168-X","article-title":"Effects of doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections on gonorrhoea prevalence and antimicrobial resistance among men who have sex with men in the USA: A modelling study.","volume":"5","author":"Reichert","year":"2024","journal-title":"Lancet Microbe"},{"key":"B48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/QAI.0000000000001791","article-title":"Choosing between daily and event-driven pre-exposure prophylaxis: Results of a belgian PrEP demonstration project.","volume":"79","author":"Reyniers","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"A244","DOI":"10.1289\/ehp.117-a244","article-title":"The landscape of antibiotic resistance.","volume":"117","author":"Rosenblatt-Farrell","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"B50","author":"Saunders","year":"2021","journal-title":"Position Statement on Doxycycline as Prophylaxis for Sexually Transmitted Infections 2021 Update. bashh.orgJM Saunders, M Kohli, NA Medland, H Fifer, D taken as PreBASHH: Lichfield, UK, 2021\u2219bashh.org."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/09564624241273801","article-title":"IUSTI Europe position statement on use of DoxyPEP: June 2024.","volume":"35","author":"Sherrard","year":"2024","journal-title":"Int. J. STD AIDS"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf089","article-title":"Potential impact of doxycycline post-exposure prophylaxis on tetracycline resistance in Neisseria gonorrhoeae and colonization with tetracycline-resistant Staphylococcus aureus and Group A Streptococcus.","author":"Soge","year":"2025","journal-title":"Clin. Infect. Dis"},{"key":"B53","article-title":"Principles of anti infective therapy","author":"Spellberg","year":"2029","journal-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases"},{"key":"B54","year":"2023"},{"key":"B55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2105\/ajph.86.5.674","article-title":"Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology.","volume":"86","author":"Susser","year":"1996","journal-title":"Am. J. Public Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"107186","DOI":"10.1016\/j.ijid.2024.107186","article-title":"Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials.","volume":"147","author":"Szondy","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad488","article-title":"Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections.","author":"Traeger","year":"2023","journal-title":"Clin. Infect. Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"dlac009","DOI":"10.1093\/jacamr\/dlac009","article-title":"A systematic review of the impacts of oral tetracycline class antibiotics on antimicrobial resistance in normal human flora.","volume":"4","author":"Truong","year":"2022","journal-title":"JAC Antimicrob. Resist."},{"key":"B59","doi-asserted-by":"publisher","first-page":"ofad165","DOI":"10.1093\/ofid\/ofad165","article-title":"Rethinking screening intensity in terms of reducing prevalence or increasing selection pressure for the emergence of resistant gonorrhea: A modeling study of men who have sex with men in Belgium.","volume":"10","author":"Tsoumanis","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/sextrans-2021-054992","article-title":"Where to go to in chlamydia control? From infection control towards infectious disease control.","volume":"97","author":"van Bergen","year":"2021","journal-title":"Sex Transm. Infect."},{"key":"B61","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/sextrans-2019-054313","article-title":"Association between STI screening intensity in men who have sex with men and gonococcal susceptibility in 21 States in the USA: An ecological study.","volume":"96","author":"Van Dijck","year":"2020","journal-title":"Sex Transm. Infect."},{"key":"B62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17843286.2024.2356337","article-title":"Belgian 2024 guidance on the use of pre-exposure prophylaxis.","volume":"79","author":"Van Praet","year":"2024","journal-title":"Acta Clin. Belg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12879-024-09275-3","article-title":"45 years of tetracycline post exposure prophylaxis for STIs and the risk of tetracycline resistance: A systematic review and meta-analysis.","volume":"24","author":"Vanbaelen","year":"","journal-title":"BMC Infect. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/09564624241239994","article-title":"Effect of mass treatment on the long-term prevalence of gonorrhoea, chlamydia and syphilis-a systematic review.","volume":"35","author":"Vanbaelen","year":"","journal-title":"Int. J. STD AIDS"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/S1473-3099(24)00502-4","article-title":"Studies of post-exposure prophylaxis with doxycycline should consider population-level selection for antimicrobial resistance.","volume":"24","author":"Vanbaelen","year":"","journal-title":"Lancet Infect. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/sextrans-2024-056381","article-title":"Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts.","volume":"101","author":"Vanbaelen","year":"","journal-title":"Sex Transm. Infect"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S1473-3099(25)00234-8","article-title":"Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae.","volume":"25","author":"Vanbaelen","year":"","journal-title":"Lancet Infect. Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/09564624241306600","article-title":"Stop classifying Neisseria gonorrhoeae as an obligate pathogen in men who have sex with men: A viewpoint.","volume":"36","author":"Vanbaelen","year":"","journal-title":"Int. J. STD AIDS"},{"key":"B69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/sextrans-2024-056261","article-title":"Doxycycline post-exposure prophylaxis among men who have sex with men and transgender women in Belgium: Awareness, use and antimicrobial resistance concerns in a cross-sectional online survey.","volume":"101","author":"Vanbaelen","year":"","journal-title":"Sex Transm. Infect."},{"key":"B70","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciad553","article-title":"Total antimicrobial consumption in doxyPEP cohorts depends on the intensity of screening for bacterial sexually transmitted infections.","volume":"78","author":"Vanbaelen","year":"","journal-title":"Clin. Infect. Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/S2352-3018(23)00299-0","article-title":"Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): Results from a randomised, multicentre, controlled trial.","volume":"11","author":"Vanbaelen","year":"","journal-title":"Lancet HIV"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e25407","DOI":"10.1002\/jia2.25407","article-title":"Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: Results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.","volume":"22","author":"Vuylsteke","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"B73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/ddg.15282","article-title":"Position statement of the German STI society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP).","volume":"22","author":"Werner","year":"2024","journal-title":"J. Deutschen Dermatol. Gesellschaft"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/S1473-3099(23)00356-0","article-title":"Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: Time to re-evaluate?","volume":"23","author":"Williams","year":"2023","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1616111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:25:44Z","timestamp":1752585944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1616111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":74,"alternative-id":["10.3389\/fmicb.2025.1616111"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1616111","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"1616111"}}